Concepedia

Kenneth J. Sansone

KJ

Statistics

Publications

1

Citations

17

H-Index

1

Active since

2023

Affiliations

RG Biopharma (United States)(Current)

Kenneth J. Sansone is an author at RG Biopharma (United States) specializing in immune function, immunodeficiencies, and clinical immunology.

Top concepts

Publications per year

2023–2023

1

Publications

1

Rademikibart (<scp>CBP</scp>‐201), a next‐generation monoclonal antibody targeting human <scp>IL‐4Rα</scp>: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis

Junying Wang, Jeffery White, Kenneth J. Sansone et al. · Clinical and Translational Science · 2023 · 17 citations · Full text

, , +17

1–1 of 1